UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Antithrombin III inhibits nuclear factor κB activation in human monocytes and vascular endothelial cells

Blood, 2002-06, Vol.99 (11), p.4015-4020

2002

Volltextzugriff (PDF)

Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes

Journal of cell science, 2002-01, Vol.115 (Pt 1), p.227-236

2002

Volltextzugriff (PDF)

Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III

Blood, 2001-02, Vol.97 (4), p.1079-1085

2001

Volltextzugriff (PDF)

Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood

Critical care medicine, 2001-01, Vol.29 (1), p.134-139

2001

Volltextzugriff (PDF)

SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2022-01, Vol.36 (1), p.41-53

2022

Volltextzugriff (PDF)

Effect of oriented or random PEGylation on bioactivity of a factor VIII inhibitor blocking peptide

Biotechnology and bioengineering, 2006-03, Vol.93 (4), p.647-655

2006

Volltextzugriff (PDF)

Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays

Journal of immunological methods, 2006-01, Vol.308 (1), p.90-100

2006

Volltextzugriff (PDF)

Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms

Thrombosis and haemostasis, 2002-08, Vol.88 (2), p.242

2002

Volltextzugriff (PDF)

Combinatorial peptides directed to inhibitory antibodies against human blood clotting factor VIII

Thrombosis and haemostasis, 2005-11, Vol.94 (5), p.933

2005

Volltextzugriff (PDF)

The Crystal Structure and Ion Channel Activity of Human Annexin II, a Peripheral Membrane Protein

Journal of molecular biology, 1996-04, Vol.257 (4), p.839-847

1996

Volltextzugriff (PDF)

Thawing of Pooled, Solvent/Detergent-Treated Plasma octaplasLG®: Validation Studies Using Different Thawing Devices

Transfusion medicine and hemotherapy, 2017-04, Vol.44 (2), p.94-98

2017

Volltextzugriff (PDF)

Octanorm [cutaquig®], a new immunoglobulin (human) subcutaneous 16.5% solution for injection (165 mg/mL) – Biochemical characterization, pathogen safety, and stability

Biologicals, 2019-07, Vol.60, p.60-67

2019

Volltextzugriff (PDF)

The calcium binding sites in human annexin V by crystal structure analysis at 2.0 A resolution Implications for membrane binding and calcium channel activity

FEBS letters, 1990-11, Vol.275 (1), p.15-21

1990

Volltextzugriff (PDF)

Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2017-04, Vol.31 (2), p.125-134

2017

Volltextzugriff (PDF)

Biochemical characterization, stability, and pathogen safety of a new fibrinogen concentrate (fibryga®)

Biologicals, 2018-03, Vol.52, p.72-77

2018

Volltextzugriff (PDF)

Gene Expression Profile Modulated by IVIG in Healthy Donors and Multiple Sclerosis Patients

Clinical immunology (Orlando, Fla.), 2007-01, Vol.123, p.S147-S147

2007

Volltextzugriff (PDF)

Biochemical characterization and stability of immune globulin intravenous 10% liquid (Panzyga®)

Biologicals, 2017-01, Vol.45, p.33-38

2017

Volltextzugriff (PDF)

The FVII Activating Protease Cleaves Single-Chain Plasminogen Activators

Haemostasis, 1999-01, Vol.29 (5), p.292-299

1999

Volltextzugriff (PDF)

Universal pooled plasma (Uniplas® ) does not induce complement-mediated hemolysis of human red blood cells in vitro

Transfusion and apheresis science, 2015-02, Vol.52 (1), p.128-135

2015

Volltextzugriff (PDF)

Factor VII Activating Protease (FSAP): A Novel Protease in Hemostasis

Biological chemistry, 2002-07, Vol.383 (7-8), p.1119-1124

Römisch, Jügrgen

2002

Volltextzugriff (PDF)

Exposure of NK cells to intravenous immunoglobulin induces IFNγ release and degranulation but inhibits their cytotoxic activity

Clinical immunology (Orlando, Fla.), 2009-12, Vol.133 (3), p.393-401

2009

Volltextzugriff (PDF)

Purification and biochemical characterization of functional complement factor H from human plasma fractions

Immunobiology (1979), 2012-11, Vol.217 (11), p.1196-1196

2012

Volltextzugriff (PDF)

A retrospective study of Octaplex in the treatment of bleeding in patients with haemophilia A complicated by inhibitors

Blood coagulation & fibrinolysis, 2010-09, Vol.21 (6), p.577-583

2010

Volltextzugriff (PDF)

Stability of solvent/detergent-treated plasma and single-donor fresh-frozen plasma during 48 h after thawing

Transfusion and apheresis science, 2005-11, Vol.33 (3), p.257-267

2005

Volltextzugriff (PDF)

Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas® ) and a development product (Uniplas® )

Transfusion and apheresis science, 2007-12, Vol.37 (3), p.223-231

2007

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Englisch
(67)
Japanisch
(19)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(44)
Science & Technology
(44)
Humans
(43)
Biological And Medical Sciences
(27)
Hematology
(22)
Fundamental And Applied Biological Sciences. Psychology
(15)
Biochemistry & Molecular Biology
(13)
Medical Sciences
(13)
Male
(11)
Adult
(10)
Amino Acid Sequence
(10)
Female
(10)
Animals
(9)
Molecular Sequence Data
(7)
Pharmacology. Drug Treatments
(7)
Proteins
(7)
Cardiovascular System & Cardiology
(6)
Cell Biology
(6)
Enzyme-Linked Immunosorbent Assay
(6)
Immunology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antithrombin III inhibits nuclear factor κB activation in human monocytes and vascular endothelial cells

Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes

Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III

Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood

SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin

Effect of oriented or random PEGylation on bioactivity of a factor VIII inhibitor blocking peptide

Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays

Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms

Combinatorial peptides directed to inhibitory antibodies against human blood clotting factor VIII

The Crystal Structure and Ion Channel Activity of Human Annexin II, a Peripheral Membrane Protein

Thawing of Pooled, Solvent/Detergent-Treated Plasma octaplasLG®: Validation Studies Using Different Thawing Devices

Octanorm [cutaquig®], a new immunoglobulin (human) subcutaneous 16.5% solution for injection (165 mg/mL) – Biochemical characterization, pathogen safety, and stability

The calcium binding sites in human annexin V by crystal structure analysis at 2.0 A resolution Implications for membrane binding and calcium channel activity

Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid

Biochemical characterization, stability, and pathogen safety of a new fibrinogen concentrate (fibryga®)

Gene Expression Profile Modulated by IVIG in Healthy Donors and Multiple Sclerosis Patients

Biochemical characterization and stability of immune globulin intravenous 10% liquid (Panzyga®)

The FVII Activating Protease Cleaves Single-Chain Plasminogen Activators

Universal pooled plasma (Uniplas® ) does not induce complement-mediated hemolysis of human red blood cells in vitro

Factor VII Activating Protease (FSAP): A Novel Protease in Hemostasis

Exposure of NK cells to intravenous immunoglobulin induces IFNγ release and degranulation but inhibits their cytotoxic activity

Purification and biochemical characterization of functional complement factor H from human plasma fractions

A retrospective study of Octaplex in the treatment of bleeding in patients with haemophilia A complicated by inhibitors

Stability of solvent/detergent-treated plasma and single-donor fresh-frozen plasma during 48 h after thawing

Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas® ) and a development product (Uniplas® )

Suchergebnisse filtern